RecruitingPhase 4NCT06367855
Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF
Sponsor
Potsawat Surabotsopon
Enrollment
60 participants
Start Date
May 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Researchers are considering Dexamethasone as preemptive medication before minimally invasive spine fusion surgery to minimize postoperative back pain with minimal side effects, aiming to enhance the effectiveness of surgery and improve patient outcomes.
Eligibility
Min Age: 50 YearsMax Age: 80 Years
Inclusion Criteria2
- Age range: 50-80 years old.
- Undergoing MIS TLIF surgery at 1-2 spinal levels.
Exclusion Criteria4
- Previously undergone spine surgery.
- HbA1C greater than or equal to 7.5 mg%
- Allergic to all types of experimental medication.
- History of using systemic steroids.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGDexamethasone
long-acting corticosteroid IV route
DRUGNormal saline
normal saline
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06367855
Related Trials
Effectiveness of WeChat-Supported Neck Rehabilitation Exercises on Early Recovery After Thyroidectomy
NCT077074011 location
Rotator Cuff Repairs With or Without BioEnthesis™ Augmentation
NCT062896865 locations
The Effect of Progressive Relaxation Exercises With Therapeutic Clown
NCT075253881 location
MDT-0123 Japan Study
NCT0741474514 locations
Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)
NCT075286381 location